Featured M&A Deals Database

Deals and recent developments offering provides an exhilarating pavement for the healthcare companies which sight to expand their boundaries and ought to capture the most of the existing market. This helps in realizing the current potential of the ongoing market transactions. They do stand as a treasured opportunity for both the major and minor companies to fasten their growth, strengthen their position and transform according to the growth. GervanoRA Data Services (GDS) aims in portraying the existing deals and developments on day to day basis which promise to assist the emerging companies to capture the insights which will drive them to craft decisions for their long term growth.

GDS provides an extensive list of deals, which can be segregated into pharma, medical device and biotechnology sectors. We broadly classify our database into variety of segments depending on the type of agreements that occurred in-between the companies involved.

Our Deals Database is designed sophisticated to track all the deals in required segments, like indication based, therapeutic area, deal value, type of deal, company name and country wise, so that one can easily analyze the M&A Deal activities and segments.

Why Choose GDS Deals Database?
• Specific to Healthcare Domain (Pharma & Medical Device)
• Customization as per Clients Requirements
• Analyst View and Monthly Reviews

Our Clients
• Pharmaceutical Companies
• Medical Device Companies
• Biotechnology Companies
• Investors (Banks)
• Research Institutes
• Venture Capital Firms
• Healthcare Domain Investment Advisors
• Principal Investigators
• Top level Executives

enquiry2

  • Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis Business
    Genesis Biotechnology Group Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch
    Globus Medical Acquires Robotics Developer KB Medical
    Invitae Acquire Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life
    Johnson & Johnson Vision Announces Agreement to Acquire TearScience
    Mazor Robotics and Medtronic Enter Next Phase of Strategic Partnership; Medtronic to Make a $40 million Third Tranche Investment in Mazor
    Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities
    PacBio Announces New Agreement With Novogene To Purchase Ten Sequel Systems – Increases Novogene’s Capacity to Run 20 Sequel Systems at a Time
    Philips and HeartFlow Announce Global Collaboration Agreement
    RTI Surgical Divests Cardiothoracic Closure Business to A&E Medical Corporation for up to $60 Million
    Skyline Medical Signs Definitive Merger Agreement with CytoBioscience
    Straumann enters the orthodontics field and strengthens digital capabilities
    Tissue Regenix Acquires CellRight Technologies
    ZEISS continues to advance digitalization of eye care
    BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens
    BIHLERMED AND LINEUS MEDICAL PARTNERSHIP WILL ADVANCE COMFORT AND SAFETY OF IV PATIENTS
    Cohera Medical, Inc. Announces Exclusive Distribution Agreement for Cohera’s Sylys Surgical Sealant in Japan
    Endologix Announces Collaboration Agreements with Japan Lifeline for the Development and Com mercialization of Thoracic Endovascular Systems in Japan
    Fitbit’s new partnership will bring diabetes monitoring to the Ionic smartwatch
    Frazier Healthcare Partners Acquires Northfield Medical
    iQor Partners with Connected Health Innovator Nuvo Group to Deliver Healthier, Happier Pregnancies to Women Worldwide
    NuVasive Announces Acquisition of Vertera Spine
    NuvoAir Partners with Global Pharmaceutical Company to Help Physicians Early Diagnose and Monitor Respiratory Patients
    OptMed Obtains Strategic Investment and License Agreement with Synecoun
    Smiths Medical and Sommetrics Sign Distribution Agreement for New Airway Management System
    Teleflex Incorporated to Acquire NeoTract
    The Cooper Companies Announces Definitive Agreement to Acquire PARAGARD IUD from Teva
    Boston Scientific Announces Agreement to Acquire Apama Medical
    Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates
    China Biologic Agrees to Acquire TianXinFu from PWM
    CryoLife Announces Definitive Agreement to Acquire JOTEC
    iBio Announces Manufacturing Collaboration with Aethlon Medical
    Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
    Mayo-Boston Scientific Collaboration Advances with New Heart Surgery Device
    Patrona Medical and Kopis develop Medical Device utilizing Zipit’s IoT platform
    Theraclion Announces Exclusive Distribution Agreement with EDAP TMS France
    Ambu Announces Acquisition of invendo medical GmbH
    VEXIM to be Acquired by Stryker Corporation
    Salter Acquires IntuBrite, Parker Medical and InnoMed Technologies to Expand Airway Portfolio
    Arthrosurface acquires an acellular dermal technology from WASAS, LLC
    CryoLife Announces Definitive Agreement to Acquire JOTEC
    Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery
    Vyaire Medical Acquires Revolutionary Medical Devices, Inc.
    EnteroMedics Announces Acquisition Of ReShape Medical
    CHF Solutions Signs International Distribution and Services Agreement with Singapore-based TRANSMEDIC Pte Ltd.
    Dance Biopharm and Phillips-Medisize Enter into Joint Development Agreement for Advanced Inhaled Insulin Delivery
    Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells
    NanoVibronix Announces Exclusive UK Distributor for PainShield Providing Patients an Alternative to Opioids and Surgery
    Israeli startup partners with GE to help patients get quicker ultrasound reads
    Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership
    Siemens Healthineers Announces Acquisition of Fast Track Diagnostics
    Eckert & Ziegler BEBIG Purchases Manufacturer of X-Ray Devices
    Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures
    Takeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device
    Medigus Announces Distribution Agreement with Micro-Tech Europe for the MUSE System in Germany
    Medidata Expands Partnership with CytomX Therapeutics to Centralize Management of Regulated and Nonregulated Content
    GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
    Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin
    NanoVibronix Announces Morulaa HealthTech as its Regulatory & Marketing Partner in India
    The Qt Company Partners with Quantitative Imaging Systems and KDAB to Advance Cancer Research
    bioMérieux, Inc. and McKesson Medical-Surgical Announce Distribution Alliance
    Sekisui Diagnostics Enters Strategic Alliance with Mesa Biotech Inc. for Molecular POC Testing System
    Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study
    Genomic Health Announces Research Collaboration with Janssen Pharmaceuticals to Evaluate the Oncotype DX Genomic Prostate Score Test for Potential Drug Development
    Biocartis Group NV: Biocartis and Amgen Sign Companion Diagnostic Agreement for Idylla(TM) RAS Biomarker Tests
    PathoQuest and Mayo Clinic Enter into an Agreement to Conduct Study of iDTECT Blood in Patients with Febrile Neutropenia
    SPECTRAL TO LAUNCH TORAYMYXIN/EAA IN CANADA IN Q1 2018
    Medifirst Solutions Announces Agreement With Life Science Quest, LLC.
    Blue Oak and PsychoGenics Announce a Drug Discovery Partnership
    Ekso Bionics Partners with HASOMED to Launch Functional Electrical Stimulation (FES) for the EksoGT ExoskeletonCombination of Exoskeleton and RehaStim2 FES Technology Provide Breakthrough
    Underwood Foundation, International Biophysics Partner to Provide AffloVests to 50 CF Patients
    NuVasive To Acquire SafePassage
    Agendia and Bluebee Partner to Bring New NGS-based MammaPrint BluePrint Breast Cancer Kit to Market
    EIT Emerging Implant Technologies Announces Agreement with HCA
    Bodycad Announces EU Distribution and Consulting Agreement with OrthoGrow
    ChondroMimetic Update: First Partner Deal Agreed with South Korean Partner
    Centinel Spine Completes Acquisition of prodisc Assets
    iCan:Israel-Cannabis to Bring FDA Approved Nebulizers to the Medical Cannabis Market
    NanoVibronix Announces IMS Ultrasound (UK) Ltd as its Exclusive UK Distributor for UroShield Following Successful Interim Trial Results
    Fuse Medical, Inc. Signs Definitive Purchase Agreement to Acquire CPM Medical Consultants, LLC
    Skyline Medical and Helomics expand into Next Generation Sequencing for Personalized Medicine
    BD Completes Bard Acquisition, Creating New Global Health Care Leader
    Dilon Technologies Inc. acquires the CoPilot VL video laryngoscope, a premier and award-winning airway management device
    vTv Therapeutics Announces Licensing Agreement with Hangzhou Zhongmei Huadong Pharmaceutical Co. to Rights for vTv’s GLP-1r Agonist Diabetes Program in China and Other Pacific Rim Territories
    Digirad Announces Sale of its MDSS Service Contracts to Philips North
    Endonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles Lawsuit
    Wright Medical Group N.V. Announces Acquisition of IMASCAP SAS
    The Cooper Companies Acquires Paragon Vision Sciences
    Entellus Medical to be sold to Stryker for $622M
    Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLetTM
    Medtronic purchases Galway medical device company for almost €40 million
    TransEnterix Announces Global SurgiBot System Agreement
    Edwards Acquires Harpoon Medical
    LivaNova to Acquire ImThera Medical, Inc
    Smith & Nephew completes acquisition of tissue regeneration developer Rotation Medical Inc.
    Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Patients

  • Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.
    Aptevo Therapeutics Signs Agreement for Up to $74.5 Million to Sell Hyperimmune Commercial Products
    AstraZeneca and Takeda establish collaboration to develop and commercialize MEDI1341 for Parkinson’s disease
    Bristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo (nivolumab) and DS-8201 in HER2-Expressing Breast and Bladder Cancers
    Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen oncology Pipeline Focus on Innate Immunity
    Cancer Genetics Announces Transformative and Accretive Acquisition of vivoPharm, a Global Oncology & Immuno-Oncology Discovery Services Company
    Cantel Medical Acquire BHT Group in Germany
    Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company
    Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.
    CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
    Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitorfor Solid Tumors
    Dermira Enters into Agreement to License Exclusive, Worldwide Rights to Lebrikizumab
    Dr. Reddy’s Laboratories announces the out-licensing of DFD-06 to Encore dermatology
    Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group
    Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors
    Gilead Sciences Acquire Kite Pharma for $11.9 Billion
    Insilico establishes collaboration with GSK to discover novel biological targets and molecules
    Johnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative new TB Treatments
    Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products
    Mallinckrodt to Acquire InfaCare Pharmaceutical Corporation and Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice
    Mundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1
    REGENXBIO to Acquire Dimension Therapeutics
    Sanofi completes the acquisition of Protein Sciences
    Synlogic, Inc. has acquired Mirna Therapeutics, Inc.
    Topas Therapeutics signs multi-year research and option agreement with Lilly focused on immune tolerance
    WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences
    XOMA Announces Transformational License Agreements for Gevokizumab and its IL-1 Beta Intellectual Property Portfolio
    AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors
    ABIVAX and Evotec enter into Strategic Collaboration to Develop Novel Antiviral Agents
    Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions
    Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.
    BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins
    Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia and Sickle Cell Disease
    Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments
    Bristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology
    CARDIOME ANNOUNCES AGREEMENT WITH BASILEA FOR DISTRIBUTION OF ZEVTERA/MABELIO (CEFTOBIPROLE) IN EUROPE AND ISRAEL
    Catalent Signs Commercial Manufacturing Agreement with US WorldMeds for Lofexidine
    Cocrystal Pharma, HitGen and InterX Enter into Drug Discovery Collaboration
    Cooper Pharma and BioQ Pharma Enter into Strategic Partnership for Ropivacaine ReadyfusOR in Morocco
    Cryoport Selected to Support the Potential Commercial Launch of Kite Pharma’s CAR-T Therapy Axicabtagene Ciloleucel
    Geom Therapeutics Announces Agreement with National Institute of Allergy and Infectious Diseases (NIAID) for Clinical Advancement of GT-1
    HITGEN and TAKEDA Enter DNA-Encoded Library Based Drug Discovery Research Collaboration
    Immune Therapeutics, Inc. Announces Exclusive Agreement for Sale of Lodonal in Kenya Valued at Over $31 Million
    Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases
    Inventiva announces exercise of option by Boehringer Ingelheim to jointly develop potential new treatments for idiopathic pulmonary fibrosis (IPF)
    Kamada Announces Collaboration with BGN Technologies for Advanced Alpha-1 Antitrypsin Research with a Focus on Mechanism of Action
    MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
    MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia Therapies
    MediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of Singapore
    Merck KGaA Completes Divestment of Biosimilars Business
    Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology
    Mitsubishi Tanabe Pharma America Signs Agreement with Option Care for National Home Infusion Services
    Moleculin to Collaborate on Combining its WP1122 Brain Cancer Drug Candidate with Roche’s Drug Avastin
    Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapy’s
    Onxeo Grants Exclusive Worldwide License of Validive developed for the treatment of oral severe mucositis to Monopar Therapeutics
    OXIS ACQUIREs GEORGETOWN TRANSLATIONAL PHARMACEUTICALS
    Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories
    Panacea Biotech & Apotex Inc. expand collaboration to launch Prasugrel in USA
    Petra Pharma and Schrödinger Announce Research Collaboration
    PharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership
    Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II Studies
    Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
    Q BioMed Announces Development Partnership with Sphaera Pharma
    Realist Pharma and GlycoNet Announce Collaboration
    Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid Tumors
    Zavante Therapeutics Announces Agreement with NIAID to Assess ZOLYD for Lower Respiratory Tract Infections
    Zealand and Orbit Discovery enter into research collaboration
    Amgen announces new T-cell collaboration
    Athersys and Nikon CeLL Innovation to Collaborate on MultiStem Commercial Manufacturing in Japan
    Boryung to sell antihypertensive drugs in SE Asia
    Breckenridge Pharmaceutical, Inc. Announces Acquisition of 5 ANDA’s
    Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH
    DURECT and Indivior PLC Sign a $17.5 Million Patent Purchase Agreement
    GamaMabs and MedImmune Enter Licensing Agreement to Develop Antibody Drug Conjugate Targeting Cancer
    Harmony Biosciences Acquires US Rights to Pitolisant from Bioprojet; Raises $270 Million in Equity Financing
    Kaleido Biosciences and CoreBiome Partner to Accelerate Microbiome Therapeutic Development
    Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines
    Lupin Acquires Symbiomix Therapeutics LLC
    MD Anderson and BridgeBio Pharma launch Navire Pharma to develop targeted therapy for patients with difficult-to-treat cancer
    MediWound Further Expands NexoBrid’s Global Outreach through New Distribution Agreement in Taiwan with Holy Stone Healthcare
    Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company
    Recursion Pharmaceuticals Announces Research Collaboration with Takeda to Rapidly Build a Rare Disease Pipeline
    Regeneron Announces New Collaborations with HHS to Develop Antibodies against Ebola, Influenza and Multiple Other Emerging Pathogens
    Revive Therapeutics Enters into Research Collaboration with Sanyal Biotechnology for Liver Diseases
    ShangPharma Innovation and SRI International Announce Drug Discovery Collaboration
    Southern Research-Bionetix Collaboration Seeks Novel Cancer Drug That Targets a Genetic Switch
    Spero Therapeutics Licenses Exclusive Rights to SPR994, a Novel Oral Carbapenem Being Studied for Use in Adults
    Teijin Signs Exclusive License and Co-Development Agreement for Novel Botulinum Toxin in Japan
    Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors
    Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration
    Cook Pharmica Sells to Catalent in $950 Million Biopharma
    Acquisition of Ametop
    Applied BioMath, LLC Announces Collaboration with Syntimmune for Pharmacokinetic and Pharmacodynamic Modeling in Clinical Program for Autoimmune Diseases
    HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Biologic Therapies in Greater China
    Avinger Secures Waiver and Consent to CRG Loan Agreement
    Idorsia announces collaboration with Janssen Biotech on aprocitentan (ACT-132577)
    CARDIOME ANNOUNCES STRATEGIC LICENSING AGREEMENT TO COMMERCIALIZE AGGRASTAT IN RUSSIA
    Arena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China
    Proposed acquisition of Vamousse
    vTv Therapeutics and Reneo Pharmaceuticals Enter Licensing Agreement for PPAR-Delta Program
    Prime Therapeutics Signs Outcomes-Based Contract with Novo Nordisk for Type 2 Diabetes Drug Victoza (liraglutide)
    reMYND Enters Into License Agreement to Further Develop Novel Treatments Improving Beta-cell Health and Insulin Signalling With Novo Nordisk
    Hitachi to Install New Proton Beam Therapy System in Spain
    Alexion and Halozyme Enter License Agreement for ENHANZE Technology
    Astellas, the Institute of Medical Science of the University of Tokyo, Chiba University, and Asahi Kogyosha Enter into Collaborative Research Agreement on Rice-based Oral Vaccine “”MucoRice””
    DiCE Molecules Announce Multi-Year Research Collaboration with Genentech
    Cyclenium Pharma Announces Drug Discovery Collaboration Agreement with Ono Pharmaceutical
    Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
    Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy
    Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
    X-Chem and Abilita Bio Announce a Joint Research Collaboration
    Alnylam and Sanofi Submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis
    Cancer Research UK announces drug discovery collaboration with Celgene Corporation
    Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Diseases With Unmet Medical Needs
    CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
    ClearPath Development Company Launches Third Collaboration Under Strategic Partnership With Astellas Pharma To Develop Staphylococcus Aureus Vaccine With Boston Children’s Hospital
    Basilea extends existing license agreement with Pfizer for antifungal Cresemba® (isavuconazole) to Chin
    a and Asia Pacific
    Regional development and commercialisation agreement finalised with China Medical System Holdings Limited
    Scientists from SRI International and Collaborations Pharmaceuticals, Inc. Identify Potential New Ebola Virus Therapy
    Globavir Announces Partnership with SingHealth Duke-NUS Academic Medical Centre to Study Dengue Treatment
    Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API
    Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries
    Selexis SA and Turgut Pharmaceuticals Advance Partnership with Third Commercial License Agreement
    Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region
    Biogen and Ionis Enter into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular Atrophy
    Evgen Pharma and King’s collaborate to advance therapy for ischaemic stroke
    Autifony Therapeutics and Boehringer Ingelheim collaborate on a novel therapeutic approach to a range of CNS disorders
    AUSSIE CANNABIS COMPANY SIGNS 10-YEAR DISTRIBUTION DEAL IN SWITZERLAND
    Cerveau Technologies, Inc. Signs Research Agreement with KU Leuven University, Belgium
    Q Therapeutics Announces Research Collaboration With REPROCELL
    Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche
    Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington’s Disease
    PixarBio Corporation Announces Signed Agreement with Lubrizol’s Division, Particle Sciences, to cGMP Manufacture NR14 for Clinical Trials, a 14 Day Post-Surgical Pain Treatment
    Helomics Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications
    ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million
    HIKMA REACHES LICENSING AGREEMENT WITH CELLTRION FOR THIRD BIOSIMILAR PRODUCT IN THE MIDDLE EAST AND NORTH AFRICA
    Revive Therapeutics Enters into Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis and US FDA Approved Laboratory
    New partnership for the commercialization of Nucynta in the U.S. territory
    Astellas Acquires Mitobridge Under Existing Collaboration
    Xspray Pharma Enters Manufacturing Agreement With NerPharMa for its Lead Product Candidate – HyNap-Dasa
    Smart Cannabis and SinglePoint Finalize Multifaceted Joint Venture Agreement
    Cannabis Wheaton Income Corp. Announces Sustainable Growth Strategic Capital Corp. as New Wheaton Streaming Partner
    Daiichi Sankyo and Translational Sciences Conclude Agreement, after Successful Phase 1a Trial, as Part of Daiichi Sankyo Portfolio Prioritization
    Torrent Pharma completes acquisition of branded business of India and Nepal from Unichem
    Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies
    PharmaJet and Invectys partner in phase II clinical trial of DNA Cancer Vaccine
    Ambrx and TRACON Pharmaceuticals Announce Development and Commercialization Agreement for TRC105 in China
    Gilead Sciences and Kite to Acquire Cell Design Labs
    RXI Pharma (RXII) Announces Research Collaboration with Center for Cancer Immune Therapy at Herlev Hospital
    Cloaked Therapeutics
    DelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology
    Vernalis plc enters into research collaboration with Daiichi Sankyo
    I-Mab Biopharma signs licensing agreement for HyLeukin with Genexine
    MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab
    Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration
    Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy
    Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma with Gamma Secretase Inhibition
    Novel Clinical Study Collaboration Announced Designed to Improve Clinical Care for Hemophilia Patients through Innovative Personalized Treatment
    Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market
    Generex Announces Collaboration with Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China
    bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy
    Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
    BioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumors
    Five Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development Collaboration
    Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases
    Histogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese Market
    Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial
    nnovus Pharma Expands International Distribution by Signing an Exclusive Agreement in Peru with Pharma Solutions for Zestra, Zestra Glide, EjectDelay and Sensum+
    Millendo Therapeutics Announces Acquisition of Alizé Pharma SAS to Expand
    Orphan Endocrinology Pipeline
    RECORDATI: ACQUIRES TRANSIPEG, TRANSIPEGLIB AND COLOPEG FOR THE FRENCH MARKET
    Ultragenyx Sells Priority Review Voucher for $130 million
    Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae
    XCELL BIOLOGIX signs exclusive worldwide licensing agreement with the Wake Forest Institute for Regenerative Medicine for development and commercialization of novel tissue regeneration technology for healing chronic wounds and severe burns
    Veru Acquires Novel Proprietary Formulation for Overactive Bladder
    BioVectra Signs Iron Citrate Expansion Agreement with Keryx Biopharmaceuticals
    Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic in Peru
    TesoRx Pharma And ASKA Pharmaceutical Expand Territory And Scope Of Partnering Agreement For TesoRx’s Oral Testosterone Product
    ARDELYX ANNOUNCES LICENSE AGREEMENT WITH SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT COMPANY LIMITED FOR TENAPANOR IN CHINA
    Earth Science Tech Enters Negotiations for MSN-2 and Nanoderm Distribution in Three Countries and Plans New Clinical Study with HIV-Seropositive and AIDS Patients
    Navamedic ASA: Enters into partnership agreement for distribution of Zorflex in Sweden and Finland
    PerkinElmer Completes Acquisition of EUROIMMUN
    Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
    KARTELL ENTERS BIO-ON TO HELP DEVELOP NEW TECHNOLOGIES
    Regeneron and Decibel Therapeutics collaborates
    Roche and Ignyta Reach Definitive Merger Agreement
    Array BioPharma Announces Strategic Collaboration with Pfizer
    Shire and Rani Therapeutics Enter into Collaboration to Evaluate Use of the Rani Pill(TM) Technology for the Oral Delivery of Factor Therapy
    TOMI Environmental Solutions, Inc. Expands Presence in the United Kingdom With New Distribution Agreement
    Otsuka and X-Chem Enter into a Drug Discovery Research and License Collaboration



Require TOC?
Please send an inquiry to sales@gervanora.com by using “Deals and Developments TOC” as subject.